Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 12 November 2026
      Blogs
 
  09 November 2026 Staying committed: how the pharmaceutical sector is working towards its green transition

Caring for people means doing our part to care for the planet too.

Read more →
 
 
 
      What is the impact of overweight and obesity in Spain?

A recent report by the Office of Health Economics, commissioned by EFPIA, shows that elevated BMI is associated with 278,000 deaths and almost 8 million years of healthy life lost annually across eight European countries. The economic costs are equally significant, accounting for 0.6% to 1.4% of national GDP.


Elevated BMI costs Spain an estimated €19.6 billion annually (€401 per capita), split between €14.9 billion in direct costs (76%) and €4.7 billion in indirect costs (24%). Overall, expenditure related to elevated BMI amounts to roughly 1.2% of GDP, exceeding defence and housing spending.

Find out more in the report and the infographic.

 
 
 
      Events
 
 
17 NOV 2026
  Europe's Life Sciences Competitiveness Agenda - Innovation, investment and global... Hybrid

Organised by Rapporteur, this event will explore how Europe can strengthen its life sciences competitiveness and improve...

Learn more →
 
 
 
26 NOV 2026
  IHI | How to predict who will respond best to different treatments for obesity Online

Join us online on 26 November at 15:15 to find out how the SOPHIA project unlocked new insights into which patients...

Learn more →
 
 
      What we are reading
Life sciences innovation at a crossroads 06 November 2026  (EY) Read more →
Which European countries offer vaccines in pharmacies? 05 November 2026  (Vaccines Europe) Read more →
"I had three months to live": the science that has transformed health in Catalonia 02 November 2026  (Ara) Read more →
From one-size-fits-all to personalised cardiovascular care: How iCARE4CVD is turning data into... 02 October 2026  (Open Access Government) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe